CYCCP Quote, Trading Chart, Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock
home / stock / cyccp / cyccp quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-26 | 7.6 | 7.45 | 8 | 7.45 | 554 |
| 2021-02-23 | 7.38 | 7.38 | 7.38 | 7.38 | 100 |
| 2021-02-22 | 7.35 | 7.35 | 7.35 | 7.35 | 300 |
| 2021-02-16 | 7.55 | 8 | 8 | 7.55 | 488 |
| 2021-02-15 | 8.19 | 8 | 8.19 | 8 | 387 |
| 2021-02-12 | 8.19 | 8 | 8.19 | 8 | 387 |
| 2021-02-11 | 8.2 | 7.5 | 8.2 | 7.5 | 2,408 |
| 2021-02-09 | 8.99 | 8.2 | 8.99 | 8.2 | 600 |
| 2021-02-03 | 9.2 | 9.2 | 9.2 | 9.2 | 229 |
| 2021-02-01 | 8.42 | 8.0001 | 8.46 | 8.0001 | 1,189 |
| 2021-01-18 | 9.24 | 9.2 | 9.24 | 9.2 | 203 |
| 2021-01-15 | 9.24 | 9.2 | 9.24 | 9.2 | 203 |
| 2021-01-14 | 9 | 8.4 | 9.045 | 8.4 | 1,300 |
| 2021-01-13 | 8.56 | 8.56 | 8.56 | 8.56 | 420 |
| 2021-01-12 | 8.59 | 8.59 | 8.59 | 8.59 | 100 |
| 2021-01-11 | 8.99 | 8.55 | 9 | 8.45 | 1,493 |
| 2021-01-06 | 8.95 | 8.5 | 8.95 | 8.4 | 800 |
| 2021-01-05 | 8.7 | 9 | 9.35 | 8.7 | 2,759 |
| 2021-01-01 | 7.03 | 7.03 | 7.03 | 7.03 | 206 |
| 2020-12-31 | 7.03 | 7.03 | 7.03 | 7.03 | 206 |
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock Company Name:
CYCCP Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
BERKELEY HEIGHTS, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") a biopharmaceutical company developing innovative medicines based on cancer cell biology, today reported its financial results and business hig...
-
BERKELEY HEIGHTS, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce fourth quarter and full year 2020 fina...
-
BERKELEY HEIGHTS, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at the...